REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
8.10
-0.26 (-3.11%)
Mar 20, 2026, 4:00 PM EDT - Market closed
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $418.07 million as of March 23, 2026. Its market cap has increased by 30.81% in one year.
Market Cap
418.07M
Enterprise Value
437.73M
1-Year Change
30.81%
Ranking
Category
Stock Price
$8.10
Market Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $418.07M, a decrease of -44.21%. That is a compound annual growth rate of -5.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 418.10M | -42.65% |
| Dec 31, 2025 | 729.00M | 90.34% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
| Sep 17, 2015 | 749.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4D Molecular Therapeutics | 439.55M |
| Eupraxia Pharmaceuticals | 438.91M |
| Maravai LifeSciences Holdings | 436.22M |
| Century Therapeutics | 434.93M |
| Altimmune | 434.43M |
| Entrada Therapeutics | 433.00M |
| Vanda Pharmaceuticals | 420.85M |
| Neumora Therapeutics | 419.39M |